Summit Therapeutics (SMMT) Reports Q3 Loss of GBP0.08/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. TMUS
9. SPY
10. SBUX

Go back to Summit Therapeutics (SMMT) Reports Q3 Loss of GBP0.08/Share

Summit Therapeutics (SMMT) Remains an Under-the-Radar DMD Play to Watch - Oppenheimer

December 18, 2015 12:57 PM EST

Oppenheimer analyst Christopher Marai reiterated an Outperform rating and $28 price target on Summit Therapeutics plc (NASDAQ: SMMT), saying the stock remains an under-the-radar DMD play.

Marai commented, "On 12/17, Summit reported F3Q15 results, ending the quarter with £22.2M in cash. Given its... More